bud23 Antibody

Basic Research Questions

• What is BUD23 and why is it important in cellular function?

  BUD23 is a ribosomal RNA methyltransferase that imparts a methyl mark on a key guanosine residue (forming N7-methylguanosine) located between the E and P site of the small ribosomal subunit. This residue has been mapped to G1575 of yeast 18S rRNA and G1639 of human 18S rRNA . BUD23 is essential for normal ribosome maturation, with its depletion leading to nuclear accumulation of 18SE-pre-RNA . Importantly, BUD23 has dual functionality - beyond its methyltransferase activity, it plays a critical structural role in ribosome assembly that is independent of its catalytic function . In cardiac tissue, BUD23 deletion leads to severe cardiomyopathy and death, highlighting its essential role in tissues with high energy demands .

• How should researchers validate BUD23 antibodies for experimental use?

  When validating BUD23 antibodies, researchers should implement multiple complementary approaches. Western blotting validation should include positive controls (tissues known to express BUD23, such as cardiac tissue) and negative controls (BUD23 knockdown samples). Based on published studies, effective BUD23 antibody validation should demonstrate:

  • Detection of the expected ~30 kDa protein band

  • Significant reduction or absence of signal in BUD23 knockdown samples

  • Consistent results between antibody detection and mRNA expression levels

  In prostate cancer studies, researchers successfully validated BUD23 antibodies by comparing Western blot results with qPCR data after BUD23 knockdown using sgBUD23-1 and sgBUD23-2 . This dual validation approach confirms antibody specificity while also establishing knockdown efficiency.

• What cellular compartments does BUD23 localize to and how can immunostaining protocols be optimized?

  BUD23 protein is found in both the nucleus and the cytoplasm , reflecting its roles in both nuclear ribosome assembly and cytoplasmic functions. For optimal immunostaining protocols:

  • Use paraformaldehyde fixation (typically 4%) followed by permeabilization

  • Include co-staining with nuclear markers (DAPI) and/or nucleolar markers

  • Consider dual immunofluorescence with TRMT112 antibodies, as TRMT112 is an obligate binding partner that stabilizes BUD23

  • Include appropriate knockdown controls to verify staining specificity

  When performing subcellular fractionation studies, researchers should be aware that BUD23 distribution may shift based on cellular conditions, as its depletion leads to nuclear accumulation of pre-rRNA intermediates .

Advanced Research Questions

• How can researchers effectively study BUD23's role in mitochondrial function?

  BUD23's impact on mitochondrial function requires specialized experimental approaches. Based on cardiac studies, researchers should:

  • Measure mitochondrial content and function through multiple complementary assays

  • Analyze mitochondrial protein expression through proteomics

  • Assess respiratory chain complex activity

  • Evaluate mitochondrial morphology through electron microscopy

  In cardiac-specific BUD23 knockout models, proteomic analysis revealed that mitochondria were especially sensitive to BUD23 loss, with 220 mitochondrial proteins downregulated compared to only 20 upregulated . This suggests BUD23 particularly affects mitochondrial protein translation.

  Compartment	Proteins Up-regulated	Proteins Down-regulated	% of Total Down-regulated
  Mitochondrial	20	220	50%
  Translational/60S	Enriched	Minimal	-
  Proteasomal	Enriched	Minimal	-

  These findings highlight the importance of comprehensive proteomic approaches when studying BUD23's mitochondrial impacts .

• What technical considerations are important for immunoprecipitation of BUD23 in pre-ribosomal complexes?

  Immunoprecipitation of BUD23 from pre-ribosomal complexes requires careful experimental design:

  • Use C-terminally tagged BUD23 (e.g., BUD23-GFP) for immunoprecipitation

  • Include controls that bracket the time of BUD23 association with pre-40S particles (e.g., Utp9-GFP for early association and Rio2-GFP for late association)

  • Analyze co-precipitating factors by Western blotting with antibodies against specific pre-ribosomal factors

  • Consider analysis of rRNA content by Northern blotting to identify associated pre-rRNA species

  Research has shown that BUD23 co-purifies with the Rps0-cluster proteins, and its release is regulated by these factors . When investigating BUD23's dynamic association with pre-ribosomal particles, researchers should be aware that BUD23 release appears to be regulated by the binding of specific ribosomal proteins .

• How can researchers investigate BUD23's role in cancer cell proliferation?

  To study BUD23's impact on cancer cell proliferation, researchers should employ multiple complementary approaches:

  • Gene knockdown using CRISPR-Cas9 (sgBUD23) or siRNA approaches

  • Proliferation assessment through multiple methods:

    • Cell Counting Kit-8 (CCK-8) assays over 5-6 days

    • EdU incorporation assays with fluorescence microscopy

    • Colony formation assays for long-term proliferation effects

  In prostate cancer studies, BUD23 knockdown significantly inhibited cell proliferation in both PC-3 and LNCaP cell lines, as measured by CCK-8 assays over 6 days . EdU proliferation assays provided visual confirmation, showing substantially decreased DNA synthesis in BUD23-knockdown cells .

  Cell Line	Proliferation Reduction Method	Effect of BUD23 Knockdown
  PC-3	CCK-8 assay (6 days)	Marked reduction
  LNCaP	CCK-8 assay (6 days)	Significant inhibition
  PC-3	EdU incorporation	Substantial decrease
  LNCaP	EdU incorporation	Marked reduction

• How can researchers distinguish between BUD23's methyltransferase activity and its structural role?

  Distinguishing between BUD23's catalytic and structural functions requires specific experimental designs:

  • Generate catalytically inactive BUD23 mutants by targeting conserved methyltransferase domain residues

  • Compare phenotypes between complete BUD23 knockout and catalytically inactive mutants

  • Analyze 18S rRNA processing in both conditions

  • Measure m7-G1639 methylation levels using mass spectrometry

  Research has demonstrated that in both yeast and human cells, BUD23's methyltransferase catalytic activity is not required for 18S pre-RNA processing or 40S subunit synthesis . This indicates BUD23 has dual functionality - a structural role in ribosome assembly that is separate from its methyltransferase activity. Additionally, some 18S rRNA in human cells lacks the m7-G1639 mark, suggesting potential selective roles in ribosome function .

• What approaches can identify the molecular mechanism of BUD23 in the small subunit processome?

  To investigate BUD23's role in the small subunit (SSU) processome:

  • Perform genetic suppressor screens to identify factors that interact functionally with BUD23

  • Map mutations to structures of the SSU processome to visualize interaction networks

  • Conduct mass spectrometric analysis of particles isolated in the absence of BUD23

  • Use Northern blotting to assess rRNA processing defects

  Research has identified a network of SSU processome factors that genetically interact with BUD23, including DHR1, IMP4, UTP2 (NOP14), BMS1, and RPS28A . This network physically connects the 3' basal subdomain with U3-18S heteroduplex substrates, suggesting BUD23 promotes rearrangements of the 3' major domain to drive Bms1 and Dhr1 function, generating the pre-40S intermediate .

• How does TRMT112 interaction affect BUD23 function and how should this be considered in experimental design?

  TRMT112 is an obligate binding partner for BUD23, essential for its stability . When designing BUD23-related experiments:

  • Consider that BUD23 knockdown also affects TRMT112 levels due to their reciprocal stabilizing interaction

  • Include TRMT112 Western blotting when validating BUD23 knockdown

  • Recognize that TRMT112 has multiple methyltransferase binding partners, creating competitive binding relationships

  • Consider the impact on other TRMT112 clients when modulating BUD23 levels

  Research shows that TRMT112 stabilizes four client methyltransferase enzymes involved in generating the translational apparatus, with competitive binding between these clients . Therefore, BUD23 protein concentration and enzymatic function are tightly regulated at the level of protein stability through this interaction . In BUD23 knockdown experiments, TRMT112 protein was significantly downregulated, indicating their reciprocal stabilizing interaction .

• What methodologies are most effective for analyzing changes in ribosome profiles after BUD23 manipulation?

  To comprehensively analyze how BUD23 affects ribosome biogenesis and function:

  • Perform polysome profiling to assess 40S/60S subunit balance and polysome formation

  • Analyze 18S/28S rRNA ratios using bioanalyzer or qPCR approaches

  • Conduct ribosome proteomics to identify changes in ribosomal protein composition

  • Perform ribosome profiling (Ribo-seq) to assess translation efficiency of specific mRNAs

  In BUD23 knockdown studies, researchers observed an imbalance in ribosomal proteins, with upregulation of large ribosomal subunit components and downregulation of small ribosomal subunit components . In cardiac-specific BUD23 knockout mice, a significant reduction in the 18S/28S RNA ratio was observed , consistent with BUD23's role in small subunit biogenesis. These findings highlight the importance of analyzing both RNA and protein components of the ribosome when studying BUD23 function.